Skip to content
StockMarketAgent
Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

SHE/002262 stock hub

SHE/002262 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

SHE/002262is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
22.2B
Shenzhen Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
SHE/002262
In the news

Latest news · SHE/002262

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E17.2
P25 17.1P50 24.2P75 37.8
Trailing P/E20.6
P25 23.5P50 41.3P75 83.2
ROE13.5
P25 -0.9P50 4.1P75 8.8
ROIC24
P25 -0.5P50 5P75 11.4
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All SHE/002262 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
245
Groups with data
11
Currency
CNY
Showing 245 of 245 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
China
Country code
CN
Employees
6,003
Employees Change
80%
Employees Change Percent
1.35
Enterprise value
CNY 18.2B
Exchange
Shenzhen Stock Exchange
Financial currency
CNY
First seen
2026-05-10
Industry
Drug Manufacturers - Specialty & Generic
Isin
CNE100000CG8
Last refreshed
2026-05-10
Market cap
CNY 22.2B
Price
CNY 21.89
Price currency
CNY
Rev Per Employee
1,001,258x
Sector
Healthcare
Sic
2834
Symbol
she/002262
Website
https://www.nhwa-group.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

15
MetricValue
Earnings Yield
4.83%
EV Earnings
16.92x
EV/EBIT
16.25x
EV/EBITDA
13.77x
EV/FCF
38.48x
EV/Sales
3.02x
FCF yield
2.12%
Forward P/E
17.24x
P/B ratio
2.66x
P/E ratio
20.63x
P/S ratio
3.7x
PE Ratio10 Y
25.85x
PE Ratio3 Y
22.84x
PE Ratio5 Y
21.81x
PEG ratio
1.33x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

27
MetricValue
EBIT Margin
18.61%
EBITDA Margin
21.5%
FCF margin
7.86%
Gross margin
70.66%
Gross Profit
CNY 4.2B
Gross Profit Growth
-1.67%
Gross Profit Growth Q
1.26%
Gross Profit Growth3 Y
7.93%
Gross Profit Growth5 Y
9.8%
Net Income
CNY 1.1B
Net Income Growth
-8.9%
Net Income Growth Q
5.56%
Net Income Growth Quarters
1%
Net Income Growth Years
0%
Net Income Growth3 Y
4.56%
Net Income Growth5 Y
7.2%
Pretax Margin
19.84%
Profit Margin
17.87%
Profit Per Employee
CNY 178,918
Profitable Years
21
ROA
7.55
Roa5y
9.29
ROCE
13.26
ROE
13.45
Roe5y
16.44
ROIC
23.97
Roic5y
31.57

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

29
MetricValue
Cagr10y
7.97%
Cagr15y
11.36%
Cagr1y
-0.67%
Cagr3y
-7.62%
Cagr5y
9.44%
Div CAGR10
28.71%
Div CAGR3
21.64%
Div CAGR5
29.2%
EPS Growth
-9.34
EPS Growth Q
3.33
EPS Growth Quarters
1
EPS Growth Years
0
EPS Growth3 Y
4.52
EPS Growth5 Y
7.21
FCF Growth
-13.05%
FCF Growth Q
-68.47%
FCF Growth3 Y
-6.9%
FCF Growth5 Y
-13.6%
OCF Growth
-8.47%
OCF Growth Q
-50.57%
OCF Growth10 Y
17.5%
OCF Growth3 Y
-0.8%
OCF Growth5 Y
-6.31%
Revenue Growth
2.73x
Revenue Growth Q
6.58x
Revenue Growth Quarters
1x
Revenue Growth Years
5x
Revenue Growth3 Y
10.25x
Revenue Growth5 Y
11.25x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

23
MetricValue
Asset Turnover
CNY 0.65
Assets
CNY 9.6B
Cash
CNY 4.1B
Current Assets
CNY 6.9B
Current Liabilities
CNY 1.2B
Debt
CNY 95M
Debt EBITDA
CNY 0.07
Debt Equity
CNY 0.01
Debt FCF
CNY 0.2
Equity
CNY 8.3B
Interest Coverage
510.5
Liabilities
CNY 1.3B
Long Term Assets
CNY 2.8B
Long Term Liabilities
CNY 89.8M
Net Cash
CNY 4B
Net Cash By Market Cap
CNY 18.15
Net Cash Growth
2.57%
Net Debt EBITDA
CNY -3.12
Net Debt Equity
CNY -0.48
Net Debt FCF
CNY -8.54
Tangible Book Value
CNY 8.1B
Tangible Book Value Per Share
CNY 7.96
WACC
3.35

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
5.69
Inventory Turnover
2.59
Net Working Capital
CNY 1.6B
Quick ratio
5
Working Capital
CNY 5.7B
Working Capital Turnover
CNY 1.09

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

10
MetricValue
Buyback Yield
-0.48%
Dividend Growth
12.5%
Dividend Growth Years
2%
Dividend per share
CNY 0.4
Dividend Years
17
Dividend Yield
1.83%
Ex Div Date
2025-05-14
Last Dividend
CNY 0.36
Payout Frequency
Annual
Payout Ratio
34.05%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

39
MetricValue
10Y total return
115.35%
1Y total return
-0.67%
200-day SMA
24.06
3Y total return
-21.18%
50-day SMA
22.47
50-day SMA vs 200-day SMA
50under200
5Y total return
56.98%
All Time High
31.98
All Time High Change
-31.55%
All Time High Date
2023-06-06
All Time Low
1.08
All Time Low Change
1,928.73%
All Time Low Date
2008-09-08
ATR
0.48
Beta
-0.16
Beta1y
0.1
Beta2y
0.02
Ch YTD
-9.28
High
22.28
High52
29.3
High52 Date
2025-09-25
High52ch
-25.29%
Low
21.81
Low52
20.74
Low52 Date
2025-07-01
Low52ch
5.55%
Ma50ch
-2.6%
Price vs 200-day SMA
-9.02%
RSI
45.47
RSI Monthly
44.88
RSI Weekly
36.93
Sharpe ratio
-0.07x
Sortino ratio
0.12
Total Return
1.34%
Tr YTD
-9.28
Tr15y
402.4%
Tr1m
-1.57%
Tr1w
-1.79%
Tr3m
-6.29%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

6
MetricValue
Operating Income
CNY 1.1B
Operating Income Growth
-9.82
Operating Income Growth Q
7.18
Operating Income Growth3 Y
5.73
Operating Income Growth5 Y
6.37
Operating margin
18.61

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
515,034,862%
Net Borrowing
20,458,401
Shares Insiders
17.78%
Shares Institutions
11.61%
Shares Out
1,015,786,583
Shares Qo Q
4.08%
Shares Yo Y
0.48%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

63
MetricValue
Adjusted FCF
CNY 472.3M
Average Volume
11,630,680.1x
Bv Per Share
8.24
CAPEX
CNY -444.7M
Ch10y
99
Ch15y
358.9
Ch1m
-1.57
Ch1w
-1.79
Ch1y
-2.28
Ch3m
-6.29
Ch3y
-23.46
Ch5y
48.01
Ch6m
-10.47
Change
-0.77%
Change From Open
-0.41
Close
22.06
Days Gap
-0.36
Depreciation Amortization
173,625,317
Dollar Volume
257,373,601.3
Earnings Date
2026-04-18
EBIT
CNY 1.1B
EBITDA
CNY 1.3B
EPS
CNY 1.06
F Score
4
FCF
CNY 472.3M
FCF EV Yield
2.6x
FCF Per Share
CNY 0.46
Financing CF
-350,826,193
Fiscal Year End
December
Founded
1,978
Graham Number
14.02847
Graham Upside
-35.91
Income Tax
CNY 120.6M
Investing CF
-1,173,047,665
Is Primary Listing
1
Last Earnings Date
2026-04-18
Last Report Date
2026-03-31
Last Split Date
2017-05-12
Last Split Type
Forward
Lynch Fair Value
CNY 7.64
Lynch Upside
-65.11
Ma150
24.1
Ma150ch
-9.17%
Ma20
22.15
Ma20ch
-1.16%
Net CF
-607,157,891
Next Earnings Date
2026-07-30
Open
21.98
P FCF Ratio
47.08
P OCF Ratio
24.25
Payment Date
2025-05-14
Position In Range
17.02
Ppne
1,594,322,116
Price Date
2026-05-08
Price EBITDA
CNY 17.21
Ptbv Ratio
2.75
Relative Volume
1.03x
Revenue
6,010,551,752x
Tax By Revenue
2.01x
Tax Rate
10.11%
Tr6m
-10.47%
Volume
11,757,588
Z Score
13.88
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

SHE/002262 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield
+1.8%
$0.40 annual per share
Payout ratio
+34.0%
Share of earnings returned as dividends. Below 60% is generally sustainable.
5Y dividend CAGR
+29.2%
2 consecutive years of growth
Total shareholder yield
+1.3%
Next ex-dividend date: 2025-05-14
Performance

SHE/002262 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-0.7%
S&P 500 1Y: n/a
3Y total return
-21.2%
S&P 500 3Y: n/a
5Y total return
+57.0%
S&P 500 5Y: n/a
10Y total return
+115.4%
S&P 500 10Y: n/a
Ownership

Who owns SHE/002262?

Insider, institutional, and short-interest positioning.

Institutional ownership
+11.6%
Share of float held by funds and institutions
Insider ownership
+17.8%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+0.5%
Negative means the company is buying back shares.
Technical

SHE/002262 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
45.5
Neutral momentum band
Price vs 200-day MA
-9.0%
50/200-day relationship not available
Beta (5Y)
-0.16
Less volatile than the market
Sharpe ratio
-0.07
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About SHE/002262

Hub-level FAQ points readers to the deeper analysis pages.

What is the current she/002262 stock rating?

she/002262 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full she/002262 analysis?

The full report lives at /stocks/she/002262/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for she/002262?

The latest report frames she/002262 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the she/002262 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.

she/002262 stock profile: metrics, valuation and analysis | Agente de Mercado de Ações com IA